Scientists unveil prostate cancer's 'Rosetta Stone'
Almost 90 per cent of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs, a landmark new study reveals.
May 21, 2015
0
109